With every published article and case study, we learn more about desmoid tumors.
This page is a comprehensive, searchable database of desmoid tumor-related published research articles We encourage patients, researchers, and clinicians to peruse these articles with the understanding that desmoid tumor research is constantly growing and evolving.
For the latest major news and updates on desmoid tumor research and treatment, be sure to check our Newsroom.
For additional research and abstracts, please visit External Posters and Abstracts.
Search for phrases with quotes, for example “search phrase”
| Year | Authors | Title | |
|---|---|---|---|
| Year2017 | AuthorsJafri SF(1), Obaisi O(2), Vergara GG(3), Cates J(4), Singh J(5), Feeback J(6), Yandrapu H(7) | TitleDesmoid type fibromatosis: A case report with an unusual etiology | View Summary |
| Year2017 | AuthorsPavan Sugoor(1), Amit Gupta(1), Shraddha Patkar(1), Bharat Rekhi(2), Mahesh Goel(1)(3) | TitleSporadic Retroperitoneal Fibrosis: a Gentle Giant | View Summary |
| Year2017 | AuthorsJ. Souza H.M. LourenÂo G. Mendes | Title1495PLow-dose chemotherapy with methotrexate and vinblastine for desmoid tumors: A single institution experience | View Summary |
| Year2017 | AuthorsW.J. van Houdt A.K. Patel R.L. Jones M.J. Smith A. Miah C. Benson S. Zaidi C. Messiou E. Moskovic D.C. Strauss A.J. Hayes O. Husson W.T.A. van der Graaf | Title1477PDPrognosis of desmoid tumours initially managed with surveillance only at all anatomical locations | View Summary |
| Year2017 | AuthorsJimeno A(1), Gordon MS(2), Chugh R(3), Messersmith W(4), Mendelson DS(5), Dupont J(6), Stagg RJ(7), Kapoun AM(6), Xu L(8), Uttamsingh S(6), Brachmann R(6), Smith DC(3). | TitleA first-in-human Phase 1 study of the anti-cancer stem cell agent ipafricept (OMP-54F28), a decoy receptor for Wnt ligands, in patients with advanced solid tumors | View Summary |
| Year2017 | AuthorsLauro A(1), Marino IR(2), Iyer KR(3) | TitlePre-emptive Intestinal Transplant: The Surgeon’s Point of View | View Summary |
| Year2017 | AuthorsVillalobos VM(1), Hall F(2), Jimeno A(3), Gore L(3), Kern K(4), Cesari R(5), Huang B(4), Schowinsky JT(6), Blatchford PJ(3), Hoffner B(3), Elias A(3), Messersmith W(3) | TitleLong-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor | View Summary |
| Year2017 | AuthorsYang S(1), Wang X(2), Jiang H(1), Wang Y(3), Li Z(4)(5), Lu H(1) | TitleEffective Treatment of Aggressive Fibromatosis with Celecoxib Guided by Genetic testing | View Summary |
| Year2017 | AuthorsKamran Harati, Anais Jaenisch, Bjorn Behr, Ole Goertz, Ali Harati, Tobias Hirsch, Ingo Stricker, Marcus Lehnhardt, Adrien Daigeler | TitleEffect of surgical margins on prognosis in aggressive fibromatosis: A single_institutional analysis of 90 patients | View Summary |
| Year2017 | AuthorsKuba MG(1), Lester SC(1), Giess CS(2), Bertagnolli MM(3), Wieczorek TJ(4), Brock JE(1) | TitleFibromatosis of the Breast: Diagnostic Accuracy of Core Needle Biopsy | View Summary |
Continue Exploring
DTRF Funded Grants
Read about DTRF-funded research efforts which are advancing the field of desmoid tumor science.
Apply for a Grant
Are you a desmoid tumor researcher? If yes, learn more about our grant funding process here.
